Association of Adiponectin with Subclinical Atherosclerosis in a Mexican-Mestizo Population Juan Gabriel Juárez-Rojas, Rosalinda Posadas-Sánchez, María del Rocío Martínez-Alvarado, Margarita Torres-Tamayo, Esteban Jorge- Galarza, Erika Yamel Mancilla-Valenzuela, Carlos Posadas-Romero, Guillermo Celestino Cardoso-Saldaña, María del Carmen González-Salazar, Gilberto Vargas-Alarcón, Aida Xochitl Medina-Urrutia Archives of Medical Research Volume 48, Issue 1, Pages 73-78 (January 2017) DOI: 10.1016/j.arcmed.2017.01.003 Copyright © 2017 IMSS Terms and Conditions
Figure 1 Low adiponectin prevalence by presence (elevated CIMT) or absence (normal CIMT) of subclinical atherosclerosis. Archives of Medical Research 2017 48, 73-78DOI: (10.1016/j.arcmed.2017.01.003) Copyright © 2017 IMSS Terms and Conditions
Figure 2 Odds ratio of subclinical atherosclerosis (elevated CIMT) in subjects with low adiponectin levels (<8.67 μg/mL in women and <5.30 μg/mL in men) relative to those with normal adiponectin levels. Archives of Medical Research 2017 48, 73-78DOI: (10.1016/j.arcmed.2017.01.003) Copyright © 2017 IMSS Terms and Conditions